Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine versus sufentanil for anesthesia recovery in frail elderly patients undergoing laparoscopic hernia repair
ChiCTR2600133329Phase 4Not yet recruiting
- Sponsor
- Bazhong Municipal Hospital of Traditional Chinese Medicine
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Not applicable comparing Control group (sufentanil induction group) with Experimental group (oliceridine induction group) (2 arms). Primary endpoint: Time to reach target modified Aldrete score. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
Not applicable
Beyond the preview
Go deeper on ChiCTR2600133329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600133329.